BLASILIN Trademark

Trademark Overview


On Tuesday, January 4, 2022, a trademark application was filed for BLASILIN with the United States Patent and Trademark Office. The USPTO has given the BLASILIN trademark a serial number of 97201801. The federal status of this trademark filing is REGISTERED as of Tuesday, September 12, 2023. This trademark is owned by GAN & LEE PHARMACEUTICALS.. The BLASILIN trademark is filed in the Pharmaceutical Products category with the following description:

Anti-diabetic pharmaceuticals; Biological preparations for the treatment of endocrine related diseases and disorders; Chemical preparations for pharmaceutical or medical purposes, namely, for endocrine related diseases and disorders; Insulin; Medicinal herbal preparations; Medicinal preparations for metabolic system related diseases and disorders; Medicines for the treatment of gastrointestinal diseases; Pharmaceutical preparations for the treatment of Diabetes; Syringes sold filled with insulin; Syringes sold filled with anti-diabetic pharmaceuticals
blasilin

General Information


Serial Number97201801
Word MarkBLASILIN
Filing DateTuesday, January 4, 2022
Status700 - REGISTERED
Status DateTuesday, September 12, 2023
Registration Number7160338
Registration DateTuesday, September 12, 2023
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 27, 2023

Trademark Statements


Goods and ServicesAnti-diabetic pharmaceuticals; Biological preparations for the treatment of endocrine related diseases and disorders; Chemical preparations for pharmaceutical or medical purposes, namely, for endocrine related diseases and disorders; Insulin; Medicinal herbal preparations; Medicinal preparations for metabolic system related diseases and disorders; Medicines for the treatment of gastrointestinal diseases; Pharmaceutical preparations for the treatment of Diabetes; Syringes sold filled with insulin; Syringes sold filled with anti-diabetic pharmaceuticals
Translation of Words in MarkThe wording "Blasilin" has no meaning in a foreign language.

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, January 7, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameGAN & LEE PHARMACEUTICALS.
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressBEIJING 101109
CN

Party NameGAN & LEE PHARMACEUTICALS.
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressBEIJING 101109
CN

Party NameGAN & LEE PHARMACEUTICALS.
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressBEIJING 101109
CN

Trademark Events


Event DateEvent Description
Tuesday, September 12, 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, September 12, 2023REGISTERED-PRINCIPAL REGISTER
Tuesday, June 27, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 27, 2023PUBLISHED FOR OPPOSITION
Wednesday, June 7, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, May 23, 2023ELECTRONIC RECORD REVIEW COMPLETE
Friday, May 19, 2023ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
Monday, May 15, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, April 27, 2023NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Thursday, April 27, 2023INQUIRY TO SUSPENSION E-MAILED
Thursday, April 27, 2023SUSPENSION INQUIRY WRITTEN
Thursday, April 20, 2023SUSPENSION CHECKED ¿ TO ATTORNEY FOR ACTION
Monday, February 13, 2023TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Thursday, October 13, 2022NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Thursday, October 13, 2022LETTER OF SUSPENSION E-MAILED
Thursday, October 13, 2022SUSPENSION LETTER WRITTEN
Monday, October 10, 2022ASSIGNED TO EXAMINER
Friday, January 7, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, January 7, 2022NEW APPLICATION ENTERED